Mohlin, Switzerland

Robert Oertli

This inventor holds 1 USPTO granted patent. Top assignee: Solco Basel Ag. Active years: 1986.


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Oertli

Introduction

Robert Oertli is a notable inventor based in Mohlin, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the preparation of biologically active extracts. His innovative approach has the potential to impact various medical applications.

Latest Patents

Oertli holds a patent for a process that involves the preparation of a biologically active extract from mammal organs, such as the thymus. The process includes comminuting the organ or cell culture to form a slurry, which leads to cell disintegration. High molecular weight substances are precipitated through heating and subsequently removed by centrifugation. The residual substances with a molecular weight greater than 10,000 are separated out using ultrafiltration. The final product is a biologically active, low-salt, sterile, pyrogen-free, and antigen-free complete extract. Notably, this process does not utilize any foreign substances or auxiliaries, other than water.

Career Highlights

Robert Oertli is associated with Solco Basel AG, where he continues to develop and refine his innovative processes. His work at the company emphasizes the importance of creating safe and effective biological extracts for medical use.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Robert Oertli's contributions to the field of biotechnology through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to lead to significant improvements in the preparation of biologically active extracts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…